ليست عنوان مقالات لاتين Neurons lose inhibitions in epilepsy Neutral soliton dynamics in t-polyacetylene — consistent picture for magnetic resonances

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neurons lose inhibitions in epilepsy

2

Neurons regenerate in absence of reactive astrocytes

3

Neurons, Cooperativity and the Role of Noise in Brain

4

Neurons, glia, and plasticity in normal brain aging

5

Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems

6

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

7

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

8

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

9

Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review

10

Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy

11

Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia

12

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

13

Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

14

Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

15

Neuron-specific susceptibility to apolipoprotein E4

16

Neuron-synapse IC chip-set for large-scale chaotic neural networks

17

Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective

18

Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties

19

Neuro-oncology for non-oncologists

20

Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50

21

Neuro-oncology: diagnosis in the spotlight

22

Neuro-oncology: new insights and advances in treatment

23

Neuro-oncology: oligodendroglioma and molecular markers

24

Neuro-oncology: setting new standards of management

25

Neuro-oncology: the growing role of chemotherapy in glioma

26

Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)

27

Neuro-Ophthalmologic Preentation of Hemicrania Continua

28

Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy

29

Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual

30

Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.

31

Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).

32

Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00

33

Neuro-optimal operation of a variable air volume HVAC&R system

34

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications

35

Neuro-otologic Manifestations of Multiple Sclerosis

36

Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study

37

Neuropathic agents and pain. New strategies

38

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

39

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

40

Neuropathic diabetic patients do not have reduced variability of plantar loading during gait

41

Neuropathic elbow arthropathy: A review of six cases

42

Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion

43

Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women

44

Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.

45

Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

46

Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain

47

Neuropathic pain

48

Neuropathic pain

49

NEUROPATHIC PAIN

50

Neuropathic pain in hereditary coproporphyria

51

Neuropathic pain in soft tissue complaints

52

Neuropathic pain research pinpoints new role for microglia

53

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

54

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

55

Neuropathic Pain: A Review of Interneuronal Disinhibition

56

Neuropathic pain: aetiology, symptoms, mechanisms, and management

57

Neuropathic symptoms and findings in women with Fabry disease

58

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

59

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

60

Neuropathies of the foot

61

Neuropathogenicity of Equine Herpesvirus 9 in Cattle

62

Neuropathologic study of long term cyanide administration to goats

63

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

64

Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

65

Neuropathological assessment of artemether-treated severe malaria

66

Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease

67

NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE

68

Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis

69

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease

70

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?

71

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

72

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

73

Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome

74

Neuropathological markers of impaired cognition in the entorhinal cortex

75

Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age

76

Neuropathological studies of brain tissue in schizophrenia

77

Neuropathologies of the self: Clinical and anatomical features

78

Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.

79

Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging

80

Neuropathology of bipolar disorder

81

Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment

82

Neuropathology of developmental abnormalities

83

Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome

84

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

85

Neuropathology of prion diseases

86

Neuropathology of the limbic system and brainstem in West syndrome

87

Neuropathology of tuberous sclerosis

88

Neuropathology of variant Creutzfeldt-Jakob disease

89

Neuropathy complicating diffuse infiltrative lymphocytosis

90

Neuropathy in type 1 diabetic renal transplanted patients

91

Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study

92

Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease

93

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

94

Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations

95

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

96

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

97

Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture

98

Neuropeptide enzyme hydrolysis in human saliva

99

Neuropeptide expression following ligation of the ferret lingual nerve

100

Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve

101

Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells

102

Neuropeptide may shift rheumatoid arthritis into remission

103

Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat

104

Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake

105

Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease

106

Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar

107

Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses

108

Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus

109

Neuropeptide Y administration into the amygdala does not affect ethanol consumption

110

Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women

111

Neuropeptide Y expression, localization and cellular transducing effects in HUVEC

112

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke

113

Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)

114

Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli

115

Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization

116

Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats

117

Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats

118

Neuropeptide Y modulation of sympathetic activity in myocardial infarction

119

Neuropeptide Y mRNA expression in interneurons in rat spinal cord

120

Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation

121

Neuropeptide Y receptors; antisecretory control of intestinal epithelial function

122

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway

123

Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep

124

Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study

125

Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats

126

Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy

127

Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation

128

Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo

129

Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.

130

Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat

131

NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES

132

Neuropeptides and endothelial injury in cutaneous vasculitis

133

Neuropeptides and obesity

134

Neuropeptides: opportunities for drug discovery

135

Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report

136

Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals

137

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease

138

Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice

139

Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model

140

Neuro-pharmacological effects of Crinum zeylanicum in mice

141

Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.

142

Neuropharmacological effects of Nigella sativa

143

Neuropharmacological effects of Ocimum basilicum and its constituents

144

Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats

145

Neuropharmacological key to cortical plasticity found

146

Neuropharmacological properties of farnesol in Murine model

147

Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice

148

Neuropharmacological studies with spect in neuropsychiatric disorders

149

Neuropharmacology of depression in aging and age-related diseases

150

Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management

151

Neuropharmacology of timing and time perception

152

Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]

153

Neurophenomenology and the study of self-consciousness

154

Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal

155

Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals

156

Neurophysiologic and intellectual evaluation of beta-thalassemia patients

157

Neurophysiologic assessment of mucopolysaccharidosis III

158

Neurophysiologic consequences of neonatal ethanol exposure in the rat

159

Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children

160

Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy

161

Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography

162

Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy

163

Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes

164

Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance

165

Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae

166

Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation

167

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes

168

Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog

169

Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system

170

Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention

171

Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS

172

Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia

173

Neurophysiological characteristics of photophobia in migraine

174

Neurophysiological correlate of clinical signs in Parkinsonʹs disease

175

Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs

176

Neurophysiological correlates of subjective significance

177

Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography

178

Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats

179

Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)

180

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine

181

Neurophysiological evidence for categorical perception of color

182

Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder

183

Neurophysiological follow-up of motor cortical output in stroke patients

184

Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis

185

Neurophysiological indices of attention to speech in children with specific language impairment

186

Neurophysiological indices of strategy development and skill acquisition

187

Neurophysiological investigation of a chronic sensory ataxia

188

Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test

189

Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes

190

Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences

191

Neurophysiological markers of early language acquisition: from syllables to sentences

192

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli

193

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man

194

Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings

195

Neurophysiological monitoring in vascular surgery

196

Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography

197

Neurophysiological self-control: Modulation in all things

198

Neurophysiological signals of working memory in normal aging

199

Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal

200

Neurophysiological study in Pelizaeus-Merzbacher disease

201

Neurophysiological study of corticomotor pathways in restless legs syndrome

202

Neurophysiological study of facial chorea in patients with Huntingtonʹs disease

203

Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood

204

Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol

205

Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat

206

Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin

207

Neurophysiologist reprimanded by UK General Medical Council

208

Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)

209

Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans

210

Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates

211

Neurophysiology and neuroanatomy of smooth pursuit in humans

212

Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies

213

Neurophysiology for Detection of High Risk for Psychosis

214

Neurophysiology in the intensive care unit: Size (of surals) matters

215

Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates

216

Neurophysiology of Rett syndrome

217

Neurophysiology of Social Conduct and Impact of Adverse Exposures

218

Neurophysiology of spasms

219

Neurophysiology of swallowing

220

Neurophysiology of the neurogenic lower urinary tract disorders

221

Neurophysiology of Touretteʹs syndrome: pathophysiological considerations

222

Neurophysiology of unimanual motor control and mirror movements

223

Neurophysiology reference tome

224

Neuro-PID tracking control of a discharge air temperature system

225

Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine

226

Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane

227

Neuropilins and semaphorins — from angiogenesis to autoimmunity

228

Neuroplasticity and schizophrenia

229

Neuroplasticity as a function of second language learning: Anatomical changes in the human brain

230

Neuroplasticity changes during space flight Original Research Article

231

Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period

232

Neuroplasticity of face primary motor cortex control of orofacial movements

233

Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements

234

Neuroplasticity: Evidence from aphasia

235

Neuropolitics gone mad

236

Neuroprophylaxis with aminophylline and magnesium sulfate?

237

Neuroprostheses for leg function after spinal-cord injury

238

Neuroprotection after cardiac arrest

239

Neuroprotection After Traumatic Brain Injury: Is There any Hope?

240

Neuroprotection against ischemic brain injury conferred by a novel nitrate ester

241

Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat

242

NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog

243

Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease

244

Neuroprotection and the role of neuroglobin

245

Neuroprotection by KATP channels

246

Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

247

Neuroprotection disappointment yet aGAIN

248

Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice

249

Neuroprotection failure in stroke

250

Neuroprotection for acute ischaemic stroke: hope reignited

251

Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design

252

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

253

Neuroprotection in Cardiac Surgery

254

Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy

255

Neuroprotection in Glaucoma

256

Neuroprotection in Glaucoma

257

Neuroprotection in multiple sclerosis

258

Neuroprotection in Parkinsonʹs Disease

259

Neuroprotection in Parkinsonʹs disease: and now for something completely different?

260

Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury

261

Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain

262

Neuroprotective activities of acai berries (Euterpe sp.): A review

263

Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins

264

Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases

265

Neuroprotective Agents for Management of Parkinson’s disease

266

Neuroprotective agents: Cannabinoids

267

Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice

268

Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines

269

Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain

270

Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy

271

Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats

272

Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior

273

Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats

274

Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity

275

Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury

276

Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells

277

Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat

278

Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat

279

Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia

280

Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy

281

Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies

282

Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation

283

Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model

284

Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia

285

Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion

286

Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits

287

Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat

288

Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse

289

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

290

Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia

291

Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

292

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

293

Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review

294

Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats

295

Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats

296

Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy

297

Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats

298

Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia

299

Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches

300

Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury

301

Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study

302

Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model

303

Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats

304

Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial

305

Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats

306

Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat

307

Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia

308

Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus

309

Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease

310

Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis

311

Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model

312

Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats

313

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model

314

Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study

315

NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN

316

Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice

317

Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study

318

Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats

319

Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,

320

Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats

321

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats

322

Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats

323

Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat

324

Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein

325

Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats

326

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review

327

Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats

328

Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats

329

Neuroprotective effects of cobalt ferrite nanoparticles coated with sumac on damaged sciatic nerve recovery

330

Neuroprotective effects of cognitive enrichment

331

Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury

332

Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review

333

Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat

334

Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro

335

Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent

336

Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2

337

Neuroprotective effects of cystamine in aged parkinsonian mice

338

Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease

339

Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study

340

Neuroprotective effects of Equisetum telmateia in rat

341

Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment

342

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke

343

Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats

344

Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats

345

Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells

346

Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies

347

Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease

348

Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats

349

Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study

350

Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells

351

Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review

352

Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study

353

Neuroprotective effects of naturally occurring biflavonoids

354

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

355

Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia

356

Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats

357

Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures

358

Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice

359

Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus

360

Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)

361

Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol

362

Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats

363

Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells

364

Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats

365

Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain

366

Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model

367

Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress

368

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

369

Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation

370

Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion

371

Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE

372

Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial

373

Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats

374

Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats

375

Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review

376

Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease

377

Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats

378

Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment

379

Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia

380

Neuroprotective effects of α-lipoic acid and its positively charged amide analogue

381

Neuroprotective gene profile in the brain of magnesium-deficient mice

382

Neuroprotective mechanism of bromocriptine

383

Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds

384

Neuroprotective Plants; What, How, an‎d Why? A Narrative Review

385

Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses

386

Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats

387

Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity

388

Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo

389

Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels

390

Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes

391

Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats

392

Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats

393

Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review

394

Neuroprotective Strategies in the Perioperative Period: A Systematic Review

395

Neuroprotective therapy for acute ischaemic stroke: down, but not out

396

Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat

397

Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review

398

Neuroproteomics comes of age

399

Neuropsychiaric perspective and recommendations

400

Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis

401

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review

402

Neuropsychiatric aspects in Munchausenʹs syndrome

403

Neuropsychiatric aspects of epilepsy in children

404

Neuropsychiatric aspects of patients with hypothalamic hamartomas

405

Neuropsychiatric changes after liver transplantation

406

Neuropsychiatric Complications Following Liver Transplantation

407

NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE

408

Neuropsychiatric Complications of COVID-19: What is to be Expected

409

Neuropsychiatric effects of medications for allergic diseases

410

Neuropsychiatric features of systemic lupus erythematosus

411

Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study

412

Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules

413

Neuropsychiatric implications of basal ganglia dysfunction

414

Neuropsychiatric Lupus

415

Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,

416

Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism

417

Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study

418

Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review

419

Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature

420

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

421

Neuropsychiatric reaction induced by abacavir

422

Neuropsychiatric reactions with mefloquine chemoprophylaxis

423

Neuropsychiatric sequelae in a case of St. Louis Encephalitis

424

Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome

425

Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt

426

Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT

427

Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy

428

Neuropsychiatry and Behavioral Neuroscience

429

Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7

430

Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.

431

Neuropsychiatry—a discipline for the future

432

Neuropsychiatryʹs offspring

433

Neuropsychiatry—The mind embrained?

434

Neuro-Psychoanalysis May Enliven the Mindbrain Sciences

435

Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,

436

Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices

437

Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading

438

Neuropsychologic Impairment in Patients with Nonepileptic Seizures

439

Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery

440

Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade

441

Neuropsychological abnormalities in cirrhosis include learning impairment

442

Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease

443

Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C

444

Neuropsychological and cognitive psychophysiological substrates of impulsive aggression

445

Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners

446

Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone

447

Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome

448

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial

449

Neuropsychological and neurological correlates in an elderly rural population

450

Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report

451

Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms

452

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study

453

Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study

454

Neuropsychological and QEEG assessment of adult ADHD

455

Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study

456

Neuropsychological aspects of epilepsy surgery

457

Neuropsychological aspects of Tourette syndrome: A review

458

Neuropsychological aspects of type of epilepsy and etiological factors in adults

459

Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia

460

Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia

461

Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)

462

Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome

463

Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues

464

Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness

465

Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample

466

Neuropsychological assessment of the blind and visually impaired

467

Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa

468

Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases

469

Neuropsychological changes and treatment compliance in older adults with sleep apnea

470

Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)

471

Neuropsychological characterization of hepatic encephalopathy

472

Neuropsychological complaint base rates in personal injury, revisited

473

Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up

474

Neuropsychological consequences of HIV in children: A review of current literature

475

Neuropsychological consequences of right thalamic haemorrhage: Case study and review

476

Neuropsychological consequences of sequential concussions in a female college basketball player

477

Neuropsychological correlates between working memory and executive functioning

478

Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample

479

Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study

480

Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease

481

Neuropsychological correlates of Gulf War syndrome

482

Neuropsychological correlates of homocysteine levels in euthymic bipolar patients

483

Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression

484

Neuropsychological correlates of opioid dependence and withdrawal

485

Neuropsychological correlates of psychopathic traits in a non-incarcerated sample

486

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

487

Neuropsychological correlates of self-reported impulsive aggression in a college sample

488

Neuropsychological correlates of violence and aggression: A review of the clinical literature

489

Neuropsychological decline following herpes zoster without encephalitis: A case study

490

Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis

491

Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type

492

Neuropsychological deficits among patients with late-onset minor and major depression

493

Neuropsychological deficits associated with chronic hepatitis C among male veterans

494

Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment

495

Neuropsychological deficits in marijuana smokers

496

Neuropsychological deficits in probands from multiply-affected schizophrenic families

497

Neuropsychological deficits of patients with chronic or acute cerebellar lesions

498

Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment

499

Neuropsychological Disorders in Patients with Brain Tumor

500

Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain

501

Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients

502

Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting

503

Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation

504

Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease

505

Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation

506

Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation

507

Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis

508

Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans

509

Neuropsychological effects of epilepsy and antiepileptic drugs

510

Neuropsychological effects of exposure to sheep dip

511

Neuropsychological effects of long-term exposure to organophosphates in sheep dip

512

Neuropsychological effects of seizures

513

Neuropsychological effects of stress on social phobia with and without comorbid depression

514

Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills

515

Neuropsychological evaluation in the diagnosis and management of sports-related concussion

516

Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp

517

Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology

518

Neuropsychological exploration of alleged mold neurotoxicity

519

Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.

520

Neuropsychological features of diffuse Lewy body disease

521

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation

522

Neuropsychological findings in adult attention deficit disorder

523

Neuropsychological findings in young-adult stroke patients

524

Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies

525

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease

526

Neuropsychological function and psychosocial status of alcohol rehabilitation program residents

527

Neuropsychological function in adults with attention-deficit hyperactivity disorder

528

Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder

529

Neuropsychological function in unmedicated recurrent brief depression

530

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease

531

Neuropsychological functioning in a subclinical obsessive-compulsive sample

532

Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders

533

Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients

534

Neuropsychological Functioning in Bipolar Disorder and Schizophrenia

535

Neuropsychological functioning in chronic lyme disease: The role of mental effort

536

Neuropsychological Functioning in Danish Gulf War Veterans

537

Neuropsychological functioning in depressed adolescent girls

538

Neuropsychological functioning in kleptomania

539

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

540

Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients

541

Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms

542

Neuropsychological functioning in people with ADHD across the lifespan

543

Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers

544

Neuropsychological functioning in trichotillomania

545

Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome

546

Neuropsychological Functioning in Youth with Bipolar Disorder

547

Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features

548

Neuropsychological functioning of dementia patients with psychosis

549

Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment

550

Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse

551

Neuropsychological functions and the BASC

552

Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction

553

Neuropsychological impairment after hemorrhagic stroke in basal ganglia

554

Neuropsychological impairment associated with compulsive hoarding

555

Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain

556

Neuropsychological information in the Wechsler adult intelligence scale—revised

557

Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages

558

Neuropsychological Manifestation in Ebola: A Concern

559

Neuropsychological measures probably facilitate heritability research of ADHD

560

Neuropsychological outcome and quantitative neuroimaging in mild head injury,

561

Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy

562

Neuropsychological outcome following focal cortical removal for intractable epilepsy in children

563

Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up

564

Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery

565

Neuropsychological Outcome of Head Injury Using a Short Battery

566

NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA

567

Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes

568

Neuropsychological parameters of pediatric migraineurs and tensioneurs

569

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder

570

Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder

571

Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data

572

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study

573

Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables

574

Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects

575

Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction

576

Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort

577

Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting

578

Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents

579

Neuropsychological performance in men and women at risk for hypertension

580

Neuropsychological performance in normal pregnancy and preeclampsia

581

Neuropsychological performance in pediatric bipolar disorder

582

Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity

583

Neuropsychological performance of a clinical sample of extremely obese individuals

584

Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder

585

Neuropsychological performance of monozygotic twins discordant for bipolar disorder

586

Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls

587

Neuropsychological performance predicts clinical recovery in bipolar patients

588

Neuropsychological predictors of adaptive living and work behaviors

589

Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry

590

Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury

591

Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment

592

Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation

593

Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients

594

Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates

595

Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia

596

Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia

597

Neuropsychological recovery from childhood moyamoya disease

598

Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation

599

Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies

600

Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia

601

Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder

602

Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study

603

Neuropsychological Test Development and Normative Data on Hispanics

604

Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia

605

Neuropsychological test performance in a cognitively intact sample of older Japanese American adults

606

Neuropsychological Test Performance in Illiterate Subjects

607

Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings

608

Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions

609

Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities

610

Neuropsychological testing of adults: further considerations for neurologists

611

Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices

612

Neuropsychological tests and SPECT in dementing disorders

613

Neuropsychological tests predict independent activities of daily living in patients with dementia

614

Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover

615

Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia

616

Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia

617

Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence

618

Neuropsychologists’ abilities to determine the predictive value of diagnostic tests

619

Neuropsychology and linguistic aphasiology: Evidence in favor of case studies

620

Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies

621

Neuropsychology of Alzheimerʹs Disease

622

Neuropsychology of bipolar disorder: a review

623

Neuropsychology of BPI and BPII

624

Neuropsychology of BPI and BPII

625

Neuropsychology of BPI and BPII

626

Neuropsychology of developmental stuttering

627

Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders

628

Neuropsychology of obsessive-compulsive disorder: a review and treatment implications

629

Neuropsychology of timing and time perception

630

Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field

631

Neuroptera in agricultural ecosystems

632

Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden

633

Neuroradiologic MR applications with multiparametric color composite display

634

Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome

635

Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients

636

Neuroradiology of spine degenerative diseases

637

Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome

638

Neurorehabilitation, the Practical Method of Returning to Work after Stroke

639

Neurorehabilitation: no more constraint for large randomised trials

640

Neuroretinal function is normal in early dementia of the Alzheimer type

641

Neurosarcoidosis

642

Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings

643

Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature

644

Neurosarcoidosis: a clinical dilemma

645

Neurosarcoidosis: a treatable cause of vestibular dysfunction

646

Neurosarcoidosis: Findings in MRI

647

Neuroscience and computing algorithms

648

Neuroscience and the soul: Competing explanations for the human experience

649

Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury

650

Neuroscience as an Insightful Decision Support Tool for Sustainable Development

651

Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy

652

Neuroscience output of China: A MEDLINE-based bibliometric study

653

Neuroscience research on the addictions: A prospectus for future ethical and policy analysis

654

Neuroscience, neuroimaging and the law

655

Neuroscience, quantum indeterminism and the Cartesian soul

656

Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium

657

Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders

658

Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation

659

Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?

660

Neuroscientific challenges to free will and responsibility

661

Neuroscientists discover disgusting regions of the brain

662

Neuroscientists hear impassioned plea from Superman

663

Neuroscientists take a BOLD step forward

664

Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System

665

Neurosensory changes of palatal mucousa following Le Fort I osteotomy

666

Neuro-short-term load forecast of the power system in Kuwait

667

Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs

668

Neuro-simulation modeling of chemical flooding

669

Neurosolver: Neuromorphic general problem solver

670

Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium

671

Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1

672

Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP

673

Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors

674

Neurosteroid analogues: synthesis of 6-aza-allopregnanolone

675

Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article

676

Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease

677

Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry

678

Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone

679

Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy

680

Neurosurgeons report gains in treatment of vascular malformations

681

Neurosurgeons wake up to awake-brain surgery

682

Neurosurgery 7000 years ago in central Italy

683

Neurosurgery in a cold climate

684

Neurosurgery Practice During the COVID-19 Pandemic

685

Neurosurgical Approaches in Demyelinating Disorders; Where are We Now?

686

Neurosurgical Care of Nonpowder Firearm Injuries: A Narrative Review of the Literature

687

Neurosurgical Development in the East, Central and Southern African (ECSA) Region

688

Neurosurgical emergencies, volumes I and II : Christopher Loftus, MD, editor. American Association of Neurological Surgeons, 1994

689

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, , , ,

690

NEUROSURGICAL IN-PATIENT PROFILE:A THREE-YEAR AUDIT IN A REGIONAL CENTRE

691

Neurosurgical management of pain: by Richard B. North and Robert M. Levy, Springer Verlag, New York, 1997, ISBN 0-387-94256-4

692

Neurosurgical Operating Room Nurse’s Roles and Responsibilities

693

Neurosurgical procedures for refractory OCD

694

Neurosurgical Procedures in Jehovah’s Witnesses: The Tema Experience

695

Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective

696

Neurosyphilis presenting as refractory status epilepticus

697

Neurosyphilis with Hydrocephalus: A Case Report

698

Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders

699

NeuroTheology and Its Convergence with NeuroQuantology

700

Neurotheology: The relationship between brain and religion.

701

Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders

702

Neurotic disorders in the elderly : J. Lindesay (ed.) Oxford University Press, Oxford (1995). xiii + 250 pp. £39.50

703

Neuroticism and academic achievement: the Furneaux Factor as a measure of academic rigour

704

Neuroticism and affective priming: Evidence for a neuroticism-linked negative schema

705

Neuroticism and attachment insecurity as predictors of bereavement outcome

706

Neuroticism and extraversion as predictors of coping styles during early adolescence

707

Neuroticism and extraversion share genetic and environmental effects with negative and positive mood spillover in a nationally representative sample

708

Neuroticism and Fibromyalgia Syndrome: A Systematic Review and Meta-analysis

709

Neuroticism and introversion: A risky combination for disordered eating among a non-clinical sample of undergraduate women

710

Neuroticism and low educational level predict the risk of posttraumatic stress disorder in women after miscarriage or stillbirth

711

Neuroticism and mental health outcomes for long-term unemployed youth attending occupational skills training programs

712

Neuroticism and self-criticism associated with posttraumatic stress disorder in a nationally representative sample

713

Neuroticism and the facilitation of the automatic orienting of attention

714

Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder

715

Neuroticism but not cardiovascular stress reactivity is associated with less longitudinal blood pressure increase

716

Neuroticism predicts normal variability in the number of circulating leucocytes

717

Neuroticism predicts resting frontal EEG asymmetry variability

718

Neuroticism prospectively predicts pain among adolescents: Results from a nationally representative sample

719

Neuroticism, alexithymia and medically unexplained symptoms

720

Neuroticism, alexithymia, negative affect, and positive affect as determinants of medically unexplained symptoms

721

Neuroticism, cognitive ability, and the metabolic syndrome: The Vietnam Experience Study

722

Neuroticism, daily hassles, and depressive symptoms: An examination of moderating and mediating effects

723

Neuroticism, depression, and depression proneness

724

Neuroticism, Life Events and Negative Thoughts in the Development of Depression in Adolescent Girls

725

Neuroticism, preattentive and attentional biases towards threat, and anxiety before and after a severe stressor: a prospective study

726

Neuroticism, psychiatric symptoms and life events

727

Neuroticism: a non-informative marker of vulnerability to psychopathology

728

Neuroticism: moderator or mediator in the relation between locus of control and depression?

729

Neurotics are dissatisfied with life, but not with services. The South Verona Outcome Project 7

730

Neurotolerability of Gadobenate Dimeglumine Evaluation of Brain Dopamine Concentration in Freely Moving Rats by Microdialysis

731

Neurotolerability of Gadobenate Dimeglumine in a Rat Model of Focal Brain Ischemia: EEG Evaluation

732

Neurotological findings in a patient with narrow internal auditory canal: a case report

733

Neurotoxic and hepatotoxic cyanotoxins removal by nanofiltration

734

Neurotoxic Disorders of Organophosphorus Compounds and Their Managements

735

Neurotoxic effect and metabolic responses induced by a mixture of six pesticides on the earthworm Aporrectodea caliginosa nocturna Original Research Article

736

Neurotoxic effect of lead on rats: Relationship to Apoptosis

737

Neurotoxic effect of linamarin in rats associated with cassava (Manihot esculenta Crantz) consumption

738

Neurotoxic Effects of 2,5-Hexanedione on Rapidly Growing Unmyelinated Peripheral Nerve Axons of a Rat Fetus: Dose–Effect Relationship

739

Neurotoxic effects of 25 mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats

740

Neurotoxic Effects of Fractionated Diesel Exhausts Following Microinjections in Rat Hippocampus and Striatum

741

Neurotoxic effects of gasoline and gasoline constituents : T. M. Burbacher. Environmental Health Perspectives Supplements, 101(Suppl. 6), 133–141

742

Neurotoxic Effects of Low Level Exposure to Manganese in Human Populations,

743

Neurotoxic Effects of Low-Level Methylmercury Contamination in the Amazonian Basin

744

Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging

745

Neurotoxic lesioning of oxytocin-sensing hindbrain neurons attenuates the satiety response to CCK-8

746

Neurotoxic marine poisoning

747

Neurotoxic Syndromes and Occupational Exposure to Solvents

748

Neurotoxicity and Behavioral Alterations Following Subchronic Administration of Aqueous Extract of Erythrophleum Ivorense Stem Bark in Mice

749

Neurotoxicity and Neuroprotective Effects of Polyimides (PI) and Polyphenylenevinylene (PPV) against Hydrogen Peroxide (H2O2)

750

Neurotoxicity and occupational exposure to PCBs

751

Neurotoxicity Associated with Occupational Exposure to Acetone, Methyl Ethyl Ketone, and Cyclohexanone,

752

Neurotoxicity from Airborne Chemicals Around a Superfund Site

753

Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation

754

Neurotoxicity of 1-bromopropane: Evidence from animal experiments and human studies

755

Neurotoxicity of 2-Bromopropane and 1-Bromopropane, Alternative Solvents for Chlorofluorocarbons,

756

Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade

757

Neurotoxicity of Coscinium fenestratum stem, a medicinal plant used in traditional medicine

758

Neurotoxicity of Dextrorphan

759

Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier

760

Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms

761

Neurotoxicity of Manganese Chloride in Neonatal and Adult CD Rats Following Subchronic (21-Day) High-Dose Oral Exposure

762

Neurotoxicity of nitroxyl: Insights into HNO and NO biochemical imbalance

763

Neurotoxicity of pre-incubated alpha-synuclein with neutral nanoliposomes on PC12 and SHSY5Y cell lines

764

Neurotoxicity of tissue plasminogen activator

765

Neurotoxicity studies on sucralose and its hydrolysis products with special reference to histopathologic and ultrastructural changes

766

Neurotoxicological manifestations among drug abusers admitted to Alexandria poison unit and Al-Mamora hospital: prospective study

767

Neurotoxin Botulinum Inserts Apoptotic Effects on Certain Cancer Cell Lines Via Neural Niche of Tumors: A Molecular Study

768

Neurotoxoplasmosios After Rituximab Therapy in Diffused Proliferative Glomerulonephritis Patient

769

NeuroTracker Three-Dimensional Multiple Object Tracking (3D-MOT): A Tool to Improve Concentration and Game Performance among Basketball Athletes

770

Neurotransmission and neuromodulation in the chemosensory carotid body

771

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake

772

Neurotransmitter amino acid—oxobenzo[f]benzopyran conjugates: synthesis and photorelease studies

773

Neurotransmitter antagonism in management of irritable bowel syndrome

774

Neurotransmitter changes in the pathophysiology of Lesch–Nyhan syndrome

775

Neurotransmitter effect of galanin on the mean plasma concentrations of growth hormone, triiodothyronine, thyroxine, and milk protein in dairy goats sannan

776

Neurotransmitter interactions in schizophrenia—therapeutic implications

777

Neurotransmitter localization in the neuroepithelial cells and unipolar neurons of the respiratory tract in the bichir, Polypterus bichir bichir G. ST-HIL

778

Neurotransmitter receptor alterations in hepatic encephalopathy: A review

779

Neurotransmitters and Neuropeptides in the Developing Human Central Nervous System A Review

780

Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis

781

Neurotransmitters and the Behavior of Individual Investors: Exploratory and Confirmatory Factor Analysis

782

Neurotransmitters and vulnerability of the developing brain

783

Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed

784

Neurotransplantation in Parkinsonʹs disease

785

Neurotrauma as an Evolving Indication for Neuromodulation

786

Neurotrauma Registries in Low- and Middle-Income Countries for Building Organized Neurotrauma Care: The LATINO Registry Experience; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”

787

Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries

788

Neurotrimin and Syndecan-1 Biomarker Levels in Patients With Decompensated Heart Failure

789

Neurotrimin is an estrogen-inducible, uterine protein that mediates sympathetic axon repulsion

790

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons

791

Neurotrophic and antileukemic daphnane diterpenoids from Synaptolepis kirkii Original Research Article

792

Neurotrophic corneal defect after diode laer cycloablation

793

Neurotrophic Corneal Ulcer after Topical Tetracaine Abuse: Management Guidelines

794

Neurotrophic Effects of Swimming and Crocin Consumption on the Rats with Obesity Induced by a High-fat Diet

795

Neurotrophic factor linked to Rettʹs syndrome

796

Neurotrophic factor linked to Rettʹs syndrome

797

Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism

798

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

799

Neurotrophic factors in the therapy of diabetic neuropathy

800

Neurotrophic peptide aldehydes: Solid phase synthesis of fellutamide B and a simplified analog

801

Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation

802

Neurotrophin receptor and tyrosine hydroxylase gene expression in aged sympathetic neurons

803

Neurotrophin regulation of development of vagal innervation of the gastrointestinal tract

804

Neurotrophin secretory pathways and synaptic plasticity Review Article

805

NEUROTROPHIN-3 (NT-3) PROMOTES REPARATIVE NEOVASCULARIZATION AND BLOOD FLOW RECOVERY IN A MOUSE MODEL OF LIMB ISCHEMIA

806

Neurotrophin-3 modifies potassium currents in isolated inner hair cells from guinea-pig cochlea

807

Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons

808

Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons

809

Neurotrophins and their receptors in early development of the mammalian nervous system

810

Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study

811

Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study

812

Neurotropin alleviates rat osteocarcinoma pain via P2X3 receptor activation in the midbrain periaqueductal gray

813

Neurotropism and neuropathological effects of selected rhabdoviruses on intranasally-infected newborn mice

814

Neurotuberculosis among Filipino children: an 11 years experience at the Philippine Childrenʹs Medical Center

815

Neurovascular bundle resection: Does it improve the margins?

816

Neuro-vascular central nervous recording/stimulating system: Using nanotechnology probes

817

Neurovascular compression syndrome with Meniereʹs disease—a report of the treatment of a patient with microvascular decompression

818

NEURO-VASCULAR CONFLICT AS CAUSATIVE FACTOR IN IDIOPATHIC TRIGEMINAL NEURALGIA

819

Neurovascular contact and blood pressure response in young, healthy, normotensive men

820

Neurovascular injury during removal of levonorgestrel implants

821

Neurovascular intervention

822

Neurovascular interventions

823

Neurovascular intervention-studies and strategies

824

Neurovegetative dystonia—Psychiatric evaluation of 40 patients diagnosed by general physicians in Brazil

825

Neurovegetative symptoms and complaints before and after voice therapy for nonorganic habitual dysphonia

826

Neurovegetative Symptoms in Multiple Sclerosis: Relationship to Depressed Mood, Fatigue, and Physical Disability

827

Neuroviual rehabilitation: recent development and future direction

828

Neurulation in the cranial region - normal and abnormal

829

Neustonic microplastic and zooplankton in the North Western Mediterranean Sea

830

NEUTIT: a computer program for evaluating equivalence volumes and ionization constants in polar non-aqueous or partially aqueous media

831

Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler

832

Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler

833

Neutral (beta)-diketiminato nickel(II) monoalkyl complexes

834

Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

835

Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

836

Neutral acetohydroxamic acid coordination to a mononuclear Ni(II) center stabilized by an intramolecular hydrogen-bonding interaction

837

Neutral additives enhance the metal-chelate affinity adsorption of nucleic acids: Role of water activity

838

Neutral adsorptive capture of particles by membranes: network modeling near the membrane isoelectric point

839

Neutral aldoses as source indicators for marine snow

840

Neutral aluminum and gallium four particle complexes in silicon carbide polytypes

841

Neutral aluminum and gallium four particle complexes in silicon carbide polytypes

842

Neutral amino acids monitoring in phenylketonuric plasma microdialysates using micellar electrokinetic chromatography and laser-induced fluorescence detection

843

Neutral analyte focusing by micelle collapse in micellar electrokinetic chromatography

844

Neutral and anionic CuO2: an ab inito study

845

Neutral and cationic (η6-arene)-ruthenium(II) complexes containing the iminophosphorane–phosphine ligand Ph2PCH2P(N-p-C5F4N)Ph2: influence of the arene ring in catalytic transfer hydrogenation of cyclohexanone

846

Neutral and cationic cyclometallated Ir(III) complexes of anthra[1,2-d]imidazole-6,11-dione-derived ligands: Syntheses, structures and spectroscopic characterisation

847

Neutral and cationic Fe(II) β-diketiminate complexes

848

Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: Synthesis and cytotoxicity

849

Neutral and cationic osmium(II)-arene metallodendrimers: Synthesis, characterisation and anticancer activity

850

Neutral and cationic palladium(II) and platinum(II) complexes of 2,2′-dipyridylamine with saccharinate: Syntheses, spectroscopic, structural, fluorescent and thermal studies

851

Neutral and cationic rare-earth metal alkyl complexes that contain bis(2-methoxyethyl)(trimethylsilyl)amine, a neutral [ONO]-type ligand

852

Neutral and cationic trimethylsilylmethyl complexes of the rare earth metals supported by a crown ether: synthesis and structural characterization

853

Neutral and charged current cross sections at high Q2 at HERA Original Research Article

854

Neutral and charged donor in a 3D quantum dot

855

Neutral and charged excitons in a quantum tube

856

Neutral and charged magnetic excitons in finite-width quantum rings

857

Neutral and charged polymers at interfaces

858

Neutral and charged polymers at interfaces

859

Neutral and dianionic iron and ruthenium 1,4-diphosphabutadiene complexes

860

Neutral and Ionic Aluminum, Gallium, and Indium Compounds Carrying Two or Three Terminal Ethynyl Groups

861

Neutral and ionic multiple hydrogen bonded moieties in crystal structure of a one tripodal Schiff base

862

Neutral and ionic multiple hydrogen bonded moieties in crystal structure of a one tripodal Schiff base

863

Neutral and ionized PAHs: contribution to the interstellar extinction

864

Neutral and negatively-charged formamide, N-methylformamide and dimethylformamide clusters Original Research Article

865

Neutral and non-neutral atmosphere: Probabilistic characterization and wind-induced response of structures

866

Neutral and positively charged excitons in quantum ring

867

Neutral and Stereospecific Tc-99m Complexes: [99mTc]N-Benzyl-3,4-di-(N-2-Mercaptoethyl)-AminoPyrrolidines (P-BAT)

868

Neutral atmosphere and crustal magnetization as factors determining differences in plasma convection and magnetic fields distribution in the ionospheres of Mars and Venus Original Research Article

869

Neutral atom imaging at Mercury

870

Neutral beam deployment on DEMO and its influence on design

871

Neutral beam injection optimization at TJ-II

872

Neutral beam injection simulation of EAST

873

Neutral beam line to study decay at the KEK 12-GeV proton synchrotron

874

Neutral beam line to study decay at the KEK 12-GeV proton synchrotron

875

Neutral Beams from Blazar Jets

876

Neutral bile acid cyclic dimers exhibit fluoride coordination by cooperative aliphatic and triazole CH segments

877

Neutral bound states in kink-like theories Original Research Article

878

Neutral carbene and vinylidene cyclopentadienyl ruthenium complexes with PPh2(2-MeC6H4)

879

Neutral carbohydrate geochemistry of particulate material (trap and core sediments) in an eutrophic lake (Aydat, France)

880

Neutral carbohydrate geochemistry of particulate material in the central equatorial Pacific

881

Neutral carbon chain free energies

882

Neutral carriers based polymeric membrane electrodes for selective determination of mercury (II) Original Research Article

883

Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1

884

Neutral chloroacetamide herbicide degradates and related compounds in Midwestern United States drinking water sources

885

Neutral coated circular inclusions in finite plane elasticity of harmonic materials

886

Neutral collective excitations in striped Hall states

887

Neutral Cu4N12 and Ag4N12 metallacycles with a para-cyclophane framework assembled from copper(I) and silver(I) pyrazolates and pyridazine

888

Neutral current compensation techniques in autonomous wind energy sources

889

Neutral current induced neutrino oscillations in a supernova

890

Neutral current neutrino–nucleon scattering within a consistent isobar model and the image resonance-background interference

891

Neutral Current Ripple Minimization in a Three-Level Rectifier

892

Neutral current wave shape analysis using wavelet for diagnosis of winding insulation of a transformer

893

Neutral currents and strangeness of the nucleon from the NuTeV experiment

894

Neutral cyanide complexes of iron: Structure and stability

895

Neutral dangling bond depletion in amorphous SiN films induced by magnetic rare-earth elements

896

Neutral degradates of chloroacetamide herbicides: Occurrence in drinking water and removal during conventional water treatment

897

Neutral density revisited

898

Neutral desorption extractive electrospray ionization mass spectrometry for fast screening sunscreen agents in cream cosmetic products

899

Neutral dimeric copper–sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line

900

Neutral dioxovanadium(V) complexes of biomimetic hydrazones ONO donor ligands of bioinorganic and medicinal relevance: Synthesis via air oxidation of bis(acetylaceto-nato)oxovanadium(IV), characterization, biological activity and 3D molecular modeling

901

Neutral dissociation processes of superexcited ethylene in the VUV region

902

Neutral DNA markers fail to detect genetic divergence in an ecologically important trait Original Research Article

903

Neutral Effect on Markers of Heart Failure, Inflammation, Endothelial Activation and Function, and Vagal Tone After High-Dose HMG-CoA Reductase Inhibition in Non-Diabetic Patients With Non-Ischemic Cardiomyopathy and Average Low-Density Lipoprotein Level

904

Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: A new target to treat portal hypertension?,

905

Neutral endopeptidase inhibition enhances endogenous ANP-induced suppression of collagen synthesis in cultured cardiac fibroblasts

906

Neutral Equations and Associated Semigroups

907

Neutral Evolution in Spatially Continuous Populations

908

Neutral Evolution of Model Proteins: Diffusion in Sequence Space and Overdispersion

909

Neutral flavor tagging for the measurement of mixing-induced violation at Belle

910

Neutral flavor tagging for the measurement of mixing-induced violation at Belle

911

Neutral gas absorption refrigeration units with methyl amine as refrigerant and hydrogen as inert gas

912

Neutral gas free molecular flow algorithm including ionization and walls for use in plasma simulations

913

Neutral guest capture by a cationic water-soluble pillar[5]arene in water

914

Neutral guests complexation with calix[4]arenes preorganised by intramolecular McMurry reaction

915

Neutral heavy leptons and electroweak baryogenesis Original Research Article

916

Neutral helium line emission for edge plasma conditions

917

Neutral heteroleptic rhenium-based M3L3L′ type metallacycles: Synthesis, structural characterization and DFT/TDDFT studies

918

Neutral Higgs sector of the MSSM without Rp

919

NEUTRAL HYDROGEN CLOUDS NEAR EARLY-TYPE DWARF GALAXIES OF THE LOCAL GROUP

920

Neutral hydrogen in M 108 (NGC 3556) and the discovery of HI supershells

921

NEUTRAL HYDROGEN IN THE POLAR RING GALAXY UGC 9796

922

Neutral impedances in fault analysis

923

Neutral inhibitors of the serine protease factor Xa

924

Neutral integral equations of retarded type Original Research Article

925

Neutral kaons in medium: decoherence effects

926

Neutral lipid accumulation at elevated temperature in conditional mutants of two microalgae species

927

Neutral lipid storage disease-a case report

928

Neutral liposome-mediated delivery process of fluorescein-modified oligonucleotides in cultured human keratinocytes

929

Neutral Loss Analysis in MALDI-MS Using an Ion-Gate Scanning Mode

930

Neutral losses: A type of important variables in prediction of branching degree for acyclic alkenes from mass spectra Original Research Article

931

Neutral meson inclusive spectra measured with ALICE

932

Neutral meson production in pp and Pb–Pb collisions at LHC

933

Neutral metacommunity clustering and SAR: River basin vs. 2-D landscape biodiversity patterns

934

Neutral metacommunity clustering and SAR: River basin vs. 2-D landscape biodiversity patterns

935

Neutral metacommunity clustering and SAR: River basin vs. 2-D landscape biodiversity patterns [Ecol. Model. 222 (June (11)) (2011) 1863–1879]

936

Neutral metacommunity clustering and SAR: River basin vs. 2-D landscape biodiversity patterns [Ecol. Model. 222 (June (11)) (2011) 1863–1879]

937

Neutral metal complex in an ionic pocket: synthesis, physicochemical properties and X-ray structure of a copper(II) complex containing neutral as well as cationic dafone ligands and dafonium perchlorate

938

Neutral mixed-valence organic monoradicals

939

Neutral modelling of agricultural landscapes by tessellation methods—Application for gene flow simulation

940

Neutral modelling of agricultural landscapes by tessellation methods—Application for gene flow simulation

941

Neutral models and the deviation from neutral pattern metric

942

Neutral models for patchy landscapes

943

Neutral models for patchy landscapes

944

Neutral models for polygonal landscapes with linear networks

945

Neutral models for polygonal landscapes with linear networks

946

Neutral models of landscape change as benchmarks in the assessment of model performance

947

Neutral molecular shuttle in acetonitrile dilute solution investigated by molecular dynamics and density functional theory

948

Neutral molecular ZnX (X=O, OH, N) compounds in a molecular beam

949

Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation

950

Neutral monosaccharides as biomarker proxies for bog-forming plants for application to palaeovegetation reconstruction in ombrotrophic peat deposits

951

Neutral monosaccharides in surface sediments of the northwestern Mediterranean Sea

952

Neutral N,N′-bis(2-pyridinecarboxamide)-1,2-ethane as sensing material for determination of lutetium(III) ions in biological and environmental samples

953

Neutral networks of sequence to shape maps

954

Neutral Ni(II) complexes based on keto-enamine salicylideneanilines active for selective dimerization of ethylene

955

Neutral nido-heteroboranes with non ionisable hydrogen as arenes in coordination

956

Neutral offspring controlling operators in genetic programming

957

Neutral palladium(II) complexes with P,N Schiff-base ligands: Synthesis, characterization and application as Suzuki–Miyaura coupling catalysts

958

Neutral palladium(II) complexes with P,N Schiff-base ligands: Synthesis, characterization and catalytic oligomerisation of ethylene

959

Neutral particle analysis on ITER: present status and prospects

960

Neutral particle analysis on ITER: present status and prospects

961

Neutral particle analyzer for studies of fast ion population in plasma

962

Neutral particle analyzer for studies of fast ion population in plasma

963

Neutral particle analyzer with energy range up to 4 MeV for both alpha particles and protons

964

Neutral particle analyzer with feedback control system on HT-7 tokamak

965

Neutral particle collisional relaxation of suprathermal distributions in aeronomy

966

Neutral particle fueling at the midplane of DIII-D

967

Neutral particle modelling and particle exhaust in the Wendelstein 7-X stellarator

968

Neutral particle release from Europa’s surface

969

Neutral p-cymene ruthenium complexes with P-stereogenic monophosphines. New catalytic precursors in enantioselective transfer hydrogenation and cyclopropanation

970

Neutral pentacoordinate silicon complexes with SiO2FC skeleton: Synthesis, structural characterization and stereodynamical behavior

971

Neutral pentacoordinate silicon complexes with SiO2FC skeleton: Synthesis, structural characterization and stereodynamical behavior

972

Neutral penta-coordinated diorganotin(IV) complexes derived from ortho-aminophenol Schiff bases: Synthesis, characterization and molecular structures

973

Neutral pentosides surfactants issued from the butadiene telomerization with pentoses: preparation and amphiphilic properties

974

Neutral persulfate digestion at sub-boiling temperature in an oven for total dissolved phosphorus determination in natural waters

975

Neutral phosphate-induced renal tubular metabolic alkalosis

976

Neutral pion distributions in PHENIX at RHIC Original Research Article

977

Neutral pion measurements in polarized proton collisions from PHENIX at RHIC Original Research Article

978

Neutral pion photoproduction from the proton near threshold

979

Neutral pion photoproduction off protons close to threshold in chiral perturbation theory

980

Neutral pion photo-production on the proton up to 1.6 GeV

981

Neutral pion production in Au + Au collisions at RHIC

982

Neutral point detection in JET

983

Neutral Points of Skylight Polarization Observed During the Total Eclipse on 11 August 1999

984

Neutral poly(3,4-ethylenedioxythiophene-2,5-diyl)s: preparation by organometallic polycondensation and their unique p-doping behavior

985

Neutral porphyrin J-aggregates in premicellar SDS solution

986

Neutral pressure behavior for diverted discharges in the Wendelstein 7-AS Stellarator

987

Neutral pressure measured by fast ionization gauge in HL-2A

988

Neutral protamine Hagedorn insulin

989

Neutral radical molecules ordered in self-assembled monolayer systems for quantum information processing

990

Neutral rains at Athens, Greece: a natural safeguard against acidification of rains

991

Neutral Red as a Probe for Confocal Laser Scanning Microscopy Studies of Plant Roots

992

Neutral red interlinked gold nanoparticles/multiwalled carbon nanotubes hybrid nanomaterial and its application for the detection of NADH

993

Neutral ruthenium(II) complexes of phenylcyanamido ligands

994

Neutral sheet normal direction determination Original Research Article

995

Neutral shift [five years of continuous operation with adjustable frequency drives]

996

Neutral silicon clusters produced by laser ablation in vacuum

997

Neutral sodium atoms release from the surfaces of the Moon and Mercury induced by meteoroid impacts

998

Neutral sodium tails in comets Original Research Article

999

Neutral solar photo-Fenton degradation of 4-nitrophenol on iron-enriched hybrid montmorillonite-alginate beads (Fe-MABs)

1000

Neutral soliton dynamics in t-polyacetylene — consistent picture for magnetic resonances

بازگشت